| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.07 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.11 | 0.07 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.085 | 0.07 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.1 | 0.08 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.08 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |